Skip to main content

MoneyWorks4Me

Solara Active Pharma Sciences informs about press release

30 Jan 2023 Evaluate

Solara Active Pharma Sciences has informed that it attached press release issued by the Company titled: ‘USFDA concludes inspection at Solara’s Visakhapatnam (Vizag) facility with zero 483 inspectional observations.’

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1823.80
Dr. Reddys Labs. 1359.25
Cipla 1397.60
Lupin 1970.00
Zydus Lifesciences 1188.00
View more..